Effects of 15-deoxy-Δ12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia

Intensive Care Medicine

Volumn 32, Issue 5, 2006, Pages 759-765

  Hauser, Balázs ^a,b   Kick, Jochen ^a   Iványi, Zsolt ^a,b   Asfar, Pierre ^a,c   Ehrmann, Ulrich ^a   Muth, Claus Martin ^a   Albicini, Maura ^a,d   Wachter, Ulrich ^a   Vogt, Josef ^a   Bauer, Michael ^e   Brückner, Uwe Bernd ^a   Radermacher, Peter ^a   Bracht, Hendrik ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF MILAN   (Italy)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cyclopentenone; LigandsIntroduction; NF B; Oxidative stress; PPAR ; Prostaglandins

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 8 ISOPROSTANE; ALANINE AMINOTRANSFERASE; ENDOTOXIN; HETASTARCH; I KAPPA B; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTOXEMIA; ENZYME ACTIVITY; FEMALE; HEART PERFORMANCE; HEMODYNAMIC PARAMETERS; HYPOTENSION; INOTROPISM; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; METABOLIC PARAMETERS; NONHUMAN; OXIDATIVE STRESS; SWINE;

ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; CYCLOPENTANES; ENDOTOXEMIA; EUROPE; HYPOTENSION; OXIDATIVE STRESS; PROSPECTIVE STUDIES; PROSTAGLANDIN D2; PROSTAGLANDINS; RANDOM ALLOCATION; RESPIRATION, ARTIFICIAL; SWINE;

EID: 33646402366     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0107-8     Document Type: Article

References (39)

1. Christman JW, Lancaster LH, Blackwell TS (1998) Nuclear factor κ B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 24:1131-1138
2. Zingarelli B, Sheehan M, Wong HR (2003) Nuclear factor-κB as a therapeutic target in critical care medicine. Crit Care Med 31:S105-S111
3. Böhrer H, Nawroth PP (1998) Nuclear factor κ B - a new therapeutic approach? Intensive Care Med 24:1129-1130
4. Senftleben U, Karin M (2002) The IKK/NF-κ B pathyway. Crit Care Med 30:S18-S26
5. Altavilla D, Squadrito G, Minutoli L, Deodato B, Bova A, Sardella A, Seminara P, Passaniti M, Urna G, Venuti SF, Caputi AP, Squadrito F (2002) Inhibition of nuclear factor-kappaB actication by IRFI 042 protects against endotoxin-induced shock. Cardiovasc Res 54:684-693
6. 2, attenuates the development of acute and chronic inflammation. Mol Pharmacol 61:997-1007
7. Cuzzocrea S, Rossi A, Pisano B, Di Paola R, Genovese T, Patel NS, Cuzzocrea E, Iananro A, Sautebin L, Fulia F, Chatterjee PK, Caputi AP, Thiemermann C (2003) Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice. Intensive Care Med 29:2016-2025
8. 2 attenuates development of zymosan-induced shock. Intensive Care Med 31:693-700
9. Mitaka C, Hirata Y, Narumi Y, Yokoyama K, Makita K, Katsuyama K, Imai T (2005) Blockade of nuclear factor-κB activation prevents hypodynamic shock and gastric hypoperfusion induced by endotoxin in anesthetized dogs. Intensive Care Med 31:718-723
10. Li N, Karin M (1999) Is NF-κ B the sensor of oxidative stress? FASEB J 12:1137-1143
11. Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2:787-795
12. Senftleben U (2003) NF-κB in critical diseases: a bad guy? Intensive Care Med 29:1873-1876
13. 12,14-PGJ2 and 2-cyclotenten-1-one: role of the heat shock proteins. Mol Pharmacol 64:85-93
14. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403:103-108
15. Gilroy DW, Colville-Nash PR, Chivers WJ, Paul-Clark MJ, Willoughby DA (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5:698-701
16. 2, ligands of the peroxisome proliferator-activated receptor-g (PPAR-g), reduce ischemia/reperfusion injury of the gut. Br J Pharmacol 140:366-376
17. 2 and ciglitazone reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 171:6827-6837
18. 2 reduced the liver injury in endotoxic shock. Eur J Pharmacol 467:257-258
19. 2 ameliorates ischemic acute renal failure. Cardiovasc Res 61:630-643
20. 2 against the multiple organ failure caused by endotoxin. Crit Care Med 32:826-831
21. 2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria. Eur J Pharmacol 498:295-301
22. 2 reduced the organ injury in hemorrhagic shock. Shock 22:555-561
23. Zingarelli B, Cook JA (2005) Peroxisome proliferator-activated receptor-g is a new therapeutic target in sepsis and inflammation. Shock 23:393-399
24. 1; their actions on smooth muscle and their inactivation on passage through the pulmonary and hepatic portal vascular beds. Br J Pharmacol 37:705-722
25. Shatney CH, Lillehei RC (1976) Effects of prostaglandins in canine endotoxin shock. Acta Biol Med Ger 35:1141-1149
26. Asfar P, Iványi Z, Bracht H, Hauser B, Pittner A, Vassilev D, Nalos M, Leverve XM, Brückner UB, Radermacher P, Fröba G (2004) HMR1402, a potassium ATP channel blocker during hyperdynamic porcine endotoxemia: effects on hepato-splanchnic oxygen exchange and metabolism. Intensive Care Med 30:957-964
27. Vassilev D, Hauser B, Bracht H, Iványi Z, Schoaff M, Asfar P, Vogt J, Wachter U, Schelzig H, Georgieff M, Brückner UB, Radermacher P, Fröba G (2004) Systemic, pulmonary, and hepatosplanchnic effects of N-acetylcysteine during long-term porcine endotoxemia. Crit Care Med 32:525-532
28. Bishop-Bailey D (2000) Peroxisome proliferators-activated receptors in the cardiovascular systems. Br J Pharmacol 129:823-834
29. Haudek SB, Spencer E, Bryant DD, White DJ, Maass D, Horton JW, Chen ZJ, Giroir BP (2001) Overexpression of cardiac I-κ Bα prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol 280:H962-H968
30. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C (2002) Ligands of the peroxisome proliferators-activated receptors (PPAR-γ and PPAR-α ) reduce myocardial infarct size. FASEB J 16:1027-1040
31. Thiemermann C (2004) Inhibition of the activation of nuclear factor kappa B to reduce myocardial reperfusion injury and infarct size. Cardiovasc Res 63:8-10
32. Onai Y, Suzuki J, Kakuta T, Maejima Y, Haraguchi G, Fukasawa H, Muto S, Itai A, Isobe M (2004) Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res 63:51-59
33. Thieringer R, Fenyk-Melody JE, Le Grand CB, Shelton BA, Detmers PA, Somers EP, Carbin L, Moller DA, Wroght SD, Berger J (2000) Activation of peroxisome proliferator-activated receptor g does not inhibit IL-6 or TNF-a responses of macrophages to lipolysaccharide in vitro or in vivo. J Immunol 164:1046-1054
34. Jarrar D, Kuebler JF, Rue LW, Matalon S, Wang P, Bland KI, Chaudry IH (2002) Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-κB and MAPK/ERK mechanisms. Am J Physiol 283:L799-L805
35. Chen ZT, Li SL, Cai EQ, Wu WL, Jin JS, Zhu B (2003) LPS induces pulmonary intravascular macrophages producing inflammatory mediators via activating NF-κB. J Cell Biochem 89:1206-1214
36. Brundage SI, Schreiber MA, Holcomb JB, Zautke N, Mastrangelo MA, Xq X, Macaitis J, Tweardy DJ (2003) Amplification of the proinflammatory transcription factor cascade increases with severity of uncontrolled hemorrhage in swine. J Surg Res 113:74-80
37. Lozano FS, Lopez-Novoa JM, Rodriguez JM, Barros MB, Garcia-Criado FJ, Nicolas JL, Parreno A, Revilla J, Gomez-Alonso A (2005) Exogenous nitric oxide modulates the systemic inflammatory response and improves kidney function after risk-situation abdomnial aortic surgery. J Vasc Surg 42:129-129
38. Kondo M, Oya-Ito T, Kumagai T, Toshihiko O, Uchida K (2001) Cyclopentenone prostaglandins as potential inducers of oxidative stress. J Biol Chem 276:12076-12083
39. Bureau F, Desmet C, Mélotte D, Jaspar F, Volanti C, Vanderplasschen A, Pastoret PP, Piette J, Lekeux P (2002) A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-κB inhibition. J Immunol 168:5318-5325